Glioblastoma, the most common and heterogeneous tumor affecting brain parenchyma, is
dismally characterized by a very poor prognosis. Thus, the search of new, more effective …

It is well known how the precise localization of glioblastoma multiforme (GBM) predicts the
direction of tumor spread in the surrounding neuronal structures. The aim of the present …

Glioblastomas (GBM) are considered one of the most aggressive tumors of the central
nervous system. The standard treatment for GBM-diagnosed patients implies surgery …

Glioblastoma is the most common and aggressive primary tumor of the central nervous
system with poor outcome. Current gold standard treatment is surgical resection followed by …

Background Normal cell BRCA1 epimutations have been associated with increased risk of
triple-negative breast cancer (TNBC). However, the fraction of TNBCs that may have BRCA1 …

Simple Summary Glioblastoma stands as the most aggressive form of adult brain cancer,
often resulting in a median survival of 14.6 months even following surgical intervention …

In recent years, there has been a significant demand for natural products as a mean of
disease prevention or as an alternative to conventional medications. The driving force for …

Glioblastoma (GBM) is a highly prevalent and deadly brain tumor with high mortality rates,
especially among adults. Despite extensive research, the underlying mechanisms driving its …

Accumulating research showed that ENC1 plays a critical role in maintaining the
physiological functions. However, little is known about its role in predicting prognosis and …

The O-6-methylguanine-DNA methyltransferase (MGMT) gene is a critical guardian of
genomic integrity. MGMT methylation in diffuse gliomas serves as an important determinant …